Altshuler Shaham’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9K Buy
102
+73
+252% +$9.62K ﹤0.01% 313
2026
Q1
$4.04K Sell
29
-4
-12% -$560 ﹤0.01% 318
2025
Q4
$4.05K Buy
+33
New +$4.01K ﹤0.01% 321
2023
Q2
– Sell
-1,414
Closed -$117K – 346
2023
Q1
$117K Sell
1,414
-442
-24% -$36.6K ﹤0.01% 121
2022
Q4
$159K Buy
1,856
+121
+7% +$9.58K 0.01% 105
2022
Q3
$109K Sell
1,735
-171
-9% -$10.8K ﹤0.01% 156
2022
Q2
$118K Buy
1,906
+251
+15% +$15.5K ﹤0.01% 175
2022
Q1
$99K Buy
1,655
+969
+141% +$61.9K ﹤0.01% 266
2021
Q4
$50K Sell
686
-1,901
-73% -$131K ﹤0.01% 422
2021
Q3
$182K Buy
2,587
+1,973
+321% +$139K ﹤0.01% 267
2021
Q2
$42K Sell
614
-524
-46% -$35K ﹤0.01% 471
2021
Q1
$74K Buy
+1,138
New +$73.4K ﹤0.01% 263
2020
Q3
– Sell
-1,239
Closed -$96K – 401
2020
Q2
$96K Buy
1,239
+1,226
+9,431% +$94K ﹤0.01% 170
2020
Q1
$1K Hold
13
– – ﹤0.01% 403
2019
Q4
$1K Buy
13
+9
+225% +$586 ﹤0.01% 446
2019
Q3
$0 Buy
+4
New +$261 ﹤0.01% 471

Other funds holding GILD

Altshuler Shaham's GILD Position: Q2 2026 in Review

Altshuler Shaham increased its Gilead Sciences (GILD) stake by 252% in Q2 2026, buying an estimated $9.62K and bringing the position to 102 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #313.

Altshuler Shaham first reported a position in GILD in Q3 2019 and has held it in 16 quarters since. The position peaked at $182K in Q3 2021. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Altshuler Shaham held 102 shares of Gilead Sciences worth $12.9K as of Q2 2026.
  • Altshuler Shaham bought 73 Gilead Sciences shares in Q2 2026, an estimated $9.62K.
  • Gilead Sciences made up ﹤0.01% of Altshuler Shaham's portfolio in Q2 2026, its #313 holding.
  • Altshuler Shaham first reported a position in Gilead Sciences in Q3 2019 and has held it in 16 quarters since.
  • Altshuler Shaham's Gilead Sciences position peaked at $182K in Q3 2021.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.